FDA Inspection 1177370 — Fougera Pharmaceuticals LLC

Fougera Pharmaceuticals LLC — FEI 2432435

The FDA completed an inspection of Fougera Pharmaceuticals LLC on Aug 10, 2022 in Melville, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Veterinary.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 10, 2022
Fiscal Year
2022
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Melville, NY (United States)

Citations

IDCFRDescription
185221 CFR 211.94(a)Reactive/Additive/Absorptive Containers/Closures
188521 CFR 211.165(b)Microbiological testing
360321 CFR 211.160(b)Scientifically sound laboratory controls

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.